Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts
Year: 2015
Type: article
Source: Journal of Medicinal Chemistry
Authors: Andiliy Lai, Mehmet Kahraman, Steven Govek, Johnny Nagasawa, Celine Bonnefous, Jackie Julien, Karensa Douglas, John Sensintaffar, Nhin Lu, Kyoung-jin Lee, Anna Aparicio, Josh Kaufman, Jing Qian, Gang Shao, Rene Prudente, Michael J. Moon, James D. Joseph, Beatrice Darimont, Daniel Brigham, Kate Grillot, Richard Heyman, Peter J. Rix, Jeffrey H. Hager, Nicholas D. Smith
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2323968754